A New Meta-Documentary Frontier
At the 2026 Telluride Film Festival, a surprise unannounced screening of “You Can See Everything” stunned audiences, marking a radical departure for co-directors Nathan Fielder and Lance Oppenheim. The 174-minute film, which chronicles the final days of freedom for former Theranos CEO Elizabeth Holmes before she began her 11-year prison sentence, eschews traditional documentary structures in favor of a “meta-documentary” approach that challenges the viewer’s perception of truth, guilt, and performance.
Filmed over 35 days in 2023 at Holmes’s Del Mar residence, the project captures an intimate, often uncomfortable portrait of a woman convicted of defrauding investors of hundreds of millions of dollars. Fielder, known for his deadpan, inquisitive style in “The Rehearsal,” embedded himself with Holmes and her partner, Billy Evans. The result is a work that exists in a “nether zone” between reality television, psychological study, and dramatized reenactment.
The Psychology of Denial
The film’s central tension arises from Fielder’s persistent efforts to understand how Holmes maintains her narrative of innocence. Despite being convicted on four counts of wire fraud in 2022, Holmes remains steadfast in her belief that the Theranos technology was functional, characterizing the lack of chemical viability as a minor technical “glitch.” Fielder’s questioning is rigorous and skeptical, yet the documentary refuses to provide a simple moral judgment. Instead, it invites the audience to observe the mechanics of a “malignant narcissist’s” reality-distortion field.
The documentary utilizes unconventional techniques to bridge the gap left by Holmes’s subsequent incarceration. When access to Holmes was cut off, Fielder brought in actress Amanda Seyfried—who famously portrayed Holmes in the Hulu miniseries The Dropout—to perform transcripts of Holmes’s own words. This meta-layer creates a hall-of-mirrors effect, where the boundaries between the real Holmes and her screen representation dissolve, highlighting the performative nature of her public persona.
Stakes and Institutional Context
The Theranos saga, which saw Holmes rise to a $9 billion valuation before the company collapsed under scrutiny from Wall Street Journal reporter John Carreyrou and regulatory bodies like the SEC and CMS, remains a potent cultural touchstone. By focusing on the “human” side of a convicted criminal, Fielder and Oppenheim have sparked debate regarding the ethics of “sympathetic voyeurism.” While some viewers may view the film as an attempt to humanize a figure responsible for significant medical fraud, the directors maintain a clinical distance, allowing the actions of Holmes and her partner to speak for themselves.
The documentary also explores the commercialization of the Holmes narrative, featuring scenes of negotiations with A24 and the chilling reality of how Holmes and Evans continued to pitch Theranos-related concepts even after her legal downfall. As the film hits theaters in October 2026, it leaves audiences with a haunting question: in an era of curated images and deep-seated denial, can we ever truly see everything?